Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
28 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
NATURAL PHARMA from Brussel, company number BE0737684505, closed financial year 2025 with a result of € 62,724 after tax. For that financial year NATURAL PHARMA recorded a gross margin of € 240,737 and equity of € 285,428. Compared with financial year 2024, the result moved from € 80,429 to € 62,724. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 285,428
▲ 28% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 62,724
▼ 22% vs 2024
Profit after tax over the fiscal year.
€ 235,609
▲ 11% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 255,428.
People and assets in 2025
€ 103,773
▼ 24% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 25,758
▼ 31% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 141,860
▼ 20% vs 2024
€ 36,868 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 157,716
▲ 7% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 41,949
▼ 13% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 250,136 | € 274,437 | € 288,881 | € 240,737 | ▼ 17% |
| Profit after taxes | € 123,349 | € 106,227 | € 80,429 | € 62,724 | ▼ 22% |
| Equity | € 208,148 | € 267,275 | € 222,704 | € 285,428 | ▲ 28% |
| Total debts | € 426,681 | € 434,640 | € 402,437 | € 377,493 | ▼ 6% |
| Cash | € 246,266 | € 307,787 | € 212,661 | € 235,609 | ▲ 11% |
| Retained profit | € 178,148 | € 237,275 | € 192,704 | € 255,428 | ▲ 33% |
| Dividend | € 0 | € 47,100 | € 125,000 | € 0 | ▼ 100% |
| Bank debt | € 248,519 | € 213,612 | € 178,063 | € 141,860 | ▼ 20% |
| Balance sheet total | € 634,829 | € 701,916 | € 625,141 | € 662,921 | ▲ 6% |
By gross margin, NATURAL PHARMA ranks 129th of 440 companies with main activity “Detailhandel in farmaceutische producten” in the Brussels Region that publish figures (fiscal year 2025).
Key figures of NATURAL PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about NATURAL PHARMA the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to NATURAL PHARMA?
What happened at NATURAL PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 62,724 (▼ 22% vs 2024). filed late Source: NBB ↗
- New establishment in Vilvoorde. KBO
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Brussel. KBO
- Ibrahim El Kaddouri became a director. NBB
In short
From € 123,349 profit in 2022 to € 62,724 profit in 2025.
Paid € 109,838 in corporate taxes since 2022.
Best year ever: 2022, with € 123,349 profit.
Paid out € 172,100 in dividends to the owners in total.
Management
Behind NATURAL PHARMA is Ibrahim El Kaddouri.
Directors
According to the 2025 annual accounts
Ibrahim El Kaddouri
Director
since 2019
Establishments
Establishment units
Physical locations of this company
Oorlogskruisenlaan 94
1120 Brussel
Oorlogskruisenlaan 135
1120 Brussel
Active since 14 November 2019
Kareelerf 16
1800 Vilvoorde
Active since 28 February 2025
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 28 companies are registered at this address.
All companies at this address →ID TEAM
€ 75,792 gross margin · 2025
NETFLY
€ 52,486 gross margin · 2025
BDMS GROUP
€ 52,618 gross margin · 2025
Cleaneau
€ 176,423 gross margin · 2025
BELGIUM AUTOS PARTS
€ 263,611 gross margin · 2025
+23 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in the Brussels Region
Same main activity (Detailhandel in farmaceutische producten), 499 active companies in the Brussels Region, largest first.
€ 580.8 million revenue · 2025 · Anderlecht
€ 326.6 million revenue · 2025 · Evere
€ 152.2 million revenue · 2025 · Anderlecht
VERTEX PHARMACEUTICALS (BELGIUM)
€ 88.9 million revenue · 2025 · Brussel
Pharmacies by Medi-Market Group
€ 61.7 million revenue · 2025 · Evere
€ 21.2 million revenue · 2025 · Brussel
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
INFOMANIAK-AS, CH
Website info
Features
Security
Network
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- EL KADDOURI Ibrahim(fondateur) 100%
Details
- Company number
- 0737.684.505
- VAT number
- BE 0737.684.505
- Registered office
- Oorlogskruisenlaan 94, 1120 Brussel
- Names & denominations
- NATURAL PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 14 November 2019
- Peppol
- Active · Active since 23 Dec 2025
- Contact
- naturalpharma.be [email protected]
- Activities · NACE
Detailhandel in farmaceutische producten